Metamark is leading a shift in urological cancer care to enable patients and their physicians to make informed tretment decisions that lead to better quality of life and lower cost of care.

LEARN MORE

Press Release

Metamark Laboratory Received Accreditation from College of American Pathologists

Cambridge Laboratory Will Serve as Primary Location for Processing ProMark™, the Company’s Newly-Launched Prostate Cancer Prognostic Test

read article
Press Release

Metamark Announces Nationwide Availability of ProMark™ Prostate Cancer Test, First-of-its-Kind Protein-Based Prognostic Test

Metamark announced today the nationwide availability of ProMark™, the first-of-its-kind protein-based biopsy test designed to improve the accuracy of prognosis for men diagnosed with prostate cancer.

read article
Displaying results 7-8 (of 12)
 |<  <  1 - 2 - 3 - 4 - 5 - 6  >  >|